FDA Approved: TOVIAZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for TOVIAZ (fesoterodine fumarate) submitted by Pfizer to update its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Toviaz (fesoterodine fumarate)

Snippet

SUPPL AP for TOVIAZ (FESOTERODINE FUMARATE)